Cite
HARVARD Citation
Merril, J. et al. (n.d.). S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii). Lupus science & medicine. pp. A26-A27. [Online].